Rosen Law Firm Files Class Action Against Agilon Health
Analysis based on 44 articles · First reported Jan 28, 2026 · Last updated Feb 16, 2026
The market is negatively impacted by the news of a securities class action lawsuit against Agilon Health, as it suggests potential financial misconduct and future liabilities for the company. Investors who purchased Agilon Health securities during the Class Period may be entitled to compensation, indicating a potential loss for them.
Rosen Law Firm has filed a securities class action lawsuit against Agilon Health, reminding investors of the March 2, 2026 lead plaintiff deadline. The lawsuit alleges that Agilon Health made false and misleading statements between February 26, 2025, and August 4, 2025, regarding its 2025 guidance and the positive financial impact of its strategic actions. The firm claims that Agilon Health recklessly issued guidance that it knew or should have known would not be achieved due to material industry headwinds and overstated the immediate positive financial impact from its strategic actions to reduce risk. Investors who purchased Agilon Health securities during this period may be entitled to compensation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard